| Name | Title | Contact Details |
|---|
The RADIANCE-HTN Clinical study is a randomized, controlled study to evaluate the Paradise Renal Denervation System intended to treat high blood pressure. The study will be in up to 40 hospitals in 5 countries (US, France, Germany, The Netherlands, UK...
Supporting IVD innovators with RA/QA/CRO, FDA/CE IVD Submission, Training, Go-to-Market support and more.
ALDA Pharmaceuticals Corp. is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management
Oncologie is a global oncology biotech company dedicated to biomarker-driven development of large & small molecules.